Page Image

Nephrology Times

Nephrology Times delivers the latest news in kidney-related treatments and technologies with the goal of better informing care decisions and improving patient outcomes.

AKI
FDA Grants Fast Track Designation to CAR T-Cell Therapy for RCC
The US Food and Drug Administration (FDA) granted a Fast Track designation to the novel drug ADI-270 for the treatment of patients with metastatic or advanced clear cell renal cell carcinoma (RCC) who have been treated with an immune checkpoint inhibitor and a vascular endothelial growth factor inhibitor. A Fast Track designation is intended to expedite the development and review of drugs that address an unmet medical need. ...
Advertisement

Latest News

Advertisement

Expert Interviews

In Print

Conferences

Podcasts

Expert Columns

Knowledge Hubs

Acute Kidney Injury
Advertisement
Advertisement
Nephrology Times Chair

Editorial Board